Evaluation of Breast Cancer Gene Type 1 (BRCA1) Protein Levels in Cancer Tissue Using Surface-Enhanced Raman Spectroscopy

Abstract

Raman spectroscopy is a chemical process that utilizes the interaction between light and matter to get significant insights into the structure or characteristics of matter. Raman spectroscopy techniques, such as quantitative evaluation, early diagnostic capabilities, and elucidation of the spectral properties of tissues, are excellent candidates for use in research. In cancer, changes in genes and proteins expressed by related genes are associated with a poor prognosis and aggressive tumor characteristics. Due to modifications and regulatory steps in protein translation, the results of the messenger RNA (mRNA) expression of genes may not correctly reflect the results of protein expression. For this reason, the mRNA and protein expressions of genes are studied in parallel in molecular studies on cancer. In our study, the breast cancer gene type 1 (BRCA1) gene, which is frequently studied in breast cancer and is relatively more difficult to measure by traditional methods due to its high molecular weight, was selected, and protein quantification was performed in tissue samples by Raman spectroscopy. With Raman spectroscopy, it is possible to obtain rapid and precise quantitative results even with a small amount of sample, so it is quite advantageous compared to traditional methods. In our study, we performed surface-enhanced Raman spectroscopy (SERS) to analyze the quantitative protein amount. SERS is a highly sensitive method for detecting compounds at low concentrations. For this purpose, magnetic nanoparticles modified with protein antibodies were used, and the target protein was withdrawn from the complex environment and transferred to an appropriate buffer environment. The calibration curve for BRCA1, which plots Raman intensity against concentration, was derived by calculating the average response reading from duplicate assays conducted under identical conditions. The BRCA1 protein levels of cells were determined from the regression curve of the BRCA1 protein. The relation between the concentration of BRCA1 protein and SERS spectrum intensity was determined to be logarithmic in the range of 300 µg·mL⁻¹ to 292 ng·mL⁻¹ (R² = 0.9928, limit of detection = 10.41 µg·mL⁻¹, and limit of quantitation = 31.24 µg·mL⁻¹).

Graphical Abstract

This is a visual representation of the abstract.

Keywords

Breast cancer gene type 1 BRCA1 surface-enhanced Raman spectroscopy SERS protein levels tissue nanoparticles

Get full access to this article

View all access options for this article.

References

Abramczyk

Brozek-Pluska

. “Raman Imaging in Biochemical and Biomedical Applications. Diagnosis and Treatment of Breast Cancer”. Chem. Rev. 2013. 113(8): 5766–5781.

Mahmood

Yang

P.C.

. “Western Blot: Technique, Theory, and Trouble Shooting”. N. Am. J. Med. Sci. 2012. 4(9): 429–434.

Ghosh

Gilda

J.E.

Gomes

A.V.

. “The Necessity of and Strategies for Improving Confidence in the Accuracy of Western Blots”. Expert Rev. Proteomics. 2014. 11(5): 549–560.

Gilda

J.E.

Ghosh

Cheah

J.X.

West

T.M.

, et al. “Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS)”. PLoS One. 2015. 10(8): E0135392.

Pillai-Kastoori

Heaton

Shiflett

S.D.

Roberts

A.C.

, et al. “Antibody Validation for Western Blot: By the User, for the User”. J. Biol. Chem. 2020. 295(4): 926–939.

Kuhar

Sil

Verma

Umapathy

. “Challenges in Application of Raman Spectroscopy to Biology and Materials”. RSC Adv. 2018. 8(46): 25888–25908. https://doi.org/10.1039/C8RA04491K

Rosen

E.M.

Fan

Pestell

R.G.

Goldberg

I.D.

. “BRCA1 Gene in Breast Cancer”. J. Cell Physiol. 2003. 196(1): 19–41.

Hawsawi

Y.M.

Al-Numair

N.S.

Sobahy

T.M.

Al-Ajmi

A.M.

, et al. “The Role of BRCA1/2 in Hereditary and Familial Breast and Ovarian Cancers”. Mol. Genet. Genomic Med. 2019. 7(9): E879.

Gorodetska

Kozeretska

Dubrovska

. “BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance”. J. Cancer. 2019. 10(9): 2109–2127.

10.

Chen

Parmigiani

. “Meta-Analysis of BRCA1 and BRCA2 Penetrance”. J. Clin. Oncol. 2007. 25(11): 1329–1333.

11.

İlhan

Guven

Dogan

Torul

, et al. “The Coupling of Immunomagnetic Enrichment of Bacteria with Paper-Based Platform”. Talanta. 2019. 201: 245–252. https://doi.org/10.1016/j.talanta.2019.04.017

12.

Chen

Luque

. “Controllable Design of Tunable Nanostructures Inside Metal–Organic Frameworks”. Chem. Soc. Rev. 2017. 46(15): 4614–4630.

13.

Long

G.L.

Winefordner

J.D.

. “Limit of Detection A Closer Look at the IUPAC Definition”. Anal. Chem. 1983. 55: 712–724.

14.

Ahi

E.E.

Torul

Zengin

Sucularlı

, et al. “A Capillary Driven Microfluidic Chip for SERS Based hCG Detection”. Biosens. Bioelectron. 2022. 195: 113660. https://doi.org/10.1016/j.bios.2021.113660

15.

Cialla

März

Böhme

Theil

, et al. “Surface-Enhanced Raman Spectroscopy (SERS): Progress and Trends”. Anal. Bioanal. Chem. 2012. 403: 27–54. https://doi.org/10.1007/S00216-011-5631-X

16.

Zhou

Z.M.

Zheng

Liu

Xie

Z.Z.

, et al. “Improving SERS Sensitivity Toward Trace Sulfonamides: The Key Role of Trade-Off Interfacial Interactions Among the Target Molecules, Anions, and Cations on the SERS Active Surface”. Anal. Chem. 2021. 93(24): 8603–8612.